Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Migraine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    November 2022
  1. LIPTON RB, Pozo-Rosich P, Blumenfeld A, Li Y, et al
    Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial.
    Neurology. 2022 Nov 17. pii: WNL.0000000000201568.
    PubMed     Abstract available


  2. KOPEL D, Gottschalk CH
    Migraine--Not Just a Numbers Game: Aim to Improve Quality of Life.
    Neurology. 2022 Nov 17. pii: WNL.0000000000201566.
    PubMed    


    October 2022
  3. DE VRIES LENTSCH S, Heleen van der Arend BW, Maassen van den Brink A, Terwindt GM, et al
    Blood Pressure in Migraine Patients Treated With Monoclonal Anti-CGRP (receptor) Antibodies: A Prospective Follow-up Study.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201008.
    PubMed     Abstract available


    September 2022
  4. ORR SL
    Status Migrainosus: One of the Most Poorly Understood but Important Complications of Migraine.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201477.
    PubMed    


  5. VANDERPLUYM JH, Mangipudi K, Mbonde AA, Gritsch D, et al
    Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of Recurrence.
    Neurology. 2022 Sep 29. pii: WNL.0000000000201382.
    PubMed     Abstract available


  6. AILANI J, Kaiser EA, Mathew PG, McAllister P, et al
    Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201332.
    PubMed     Abstract available


  7. SENG EK, Fenton BT, Wang K, Lipton RB, et al
    Frequency, Demographics, Comorbidities, and Health Care Utilization by Veterans With Migraine: A VA Nationwide Cohort Study.
    Neurology. 2022 Sep 13. pii: WNL.0000000000200888.
    PubMed     Abstract available


    August 2022
  8. IGHODARO E, Ghislain B, Scharf E, Robertson CE, et al
    Pearls & Oysters: Post Pipeline Headache Phenomenon: Nummular Headache Presenting After Intracranial Aneurysm Stenting.
    Neurology. 2022 Aug 26. pii: WNL.0000000000201157.
    PubMed     Abstract available


  9. IBRAHIMI K, Rist PM, Carpenet C, Lee Rohmann J, et al
    Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women: Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201009.
    PubMed     Abstract available


  10. SACCO S, Sposato LA
    The Challenging Puzzle of Migraine, Age, and Vascular Health.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201071.
    PubMed    


  11. LIPTON RB, Dodick D, Goadsby PJ, Burstein R, et al
    Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain Versus Moderate or Severe Pain.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201031.
    PubMed     Abstract available


  12. GALLARDO VJ, Alpuente A, Pozo-Rosich P
    Association of a Cyclical Migraine Phenotype With Disease Progression: A One-Year Time Series Analysis.
    Neurology. 2022 Aug 11. pii: WNL.0000000000200887.
    PubMed     Abstract available


    July 2022
  13. COFFMAN C, Reyes D, Hess MC, Giakas AM, et al
    Relationship Between Headache Characteristics and a Remote History of TBI in Veterans: A 10-Year Retrospective Chart Review.
    Neurology. 2022;99:e187-e198.
    PubMed     Abstract available


  14. ROSENDALE N, Guterman EL, Obedin-Maliver J, Flentje A, et al
    Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals.
    Neurology. 2022 Jul 11. pii: WNL.0000000000200941.
    PubMed     Abstract available


    April 2022
  15. MORRIS C, Ross A, Greene K, Irwin S, et al
    Outcomes That Matter to Adolescents With Continuous Headache Due to Chronic Migraine and Their Parents: A Pilot Survey Study.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200292.
    PubMed     Abstract available


    March 2022
  16. DOHRN MF, Rebelo AP, Srivastava S, Cappuccio G, et al
    De Novo ATP1A1 Variants in an Early-Onset Complex Neurodevelopmental Syndrome.
    Neurology. 2022;98:440-445.
    PubMed     Abstract available


    February 2022
  17. SCHER AI, Bendtsen L
    Patient-Centered Treatment of Chronic Migraine With Medication Overuse: More Is Not Always Better.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200252.
    PubMed    


  18. MCELWEE DECKER B, Thibault D, Davis KA, Willis AW, et al
    Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200007.
    PubMed     Abstract available


  19. SCHWEDT T, Hentz J, Sahai-Srivastava S, Murinova N, et al
    Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200117.
    PubMed     Abstract available


    January 2022
  20. DUMKRIEGER G, Chong CD, Ross K, Berisha V, et al
    Differentiating Between Migraine and Post-traumatic Headache Using a Machine Learning Classifier.
    Neurology. 2022;98.
    PubMed     Abstract available


  21. ISHII R, Dodick DW, Trivedi M, Dumkrieger G, et al
    A History of Mild Traumatic Brain Injury Is Associated With a a More Severe Long-term Migraine Phenotype.
    Neurology. 2022;98.
    PubMed     Abstract available


    October 2021
  22. MACGREGOR EA
    Differences Between Perimenstrual Migraine Attacks and Migraine Attacks at Other Times of the Cycle.
    Neurology. 2021;97:e1753-e1756.
    PubMed    


  23. RIANT F, Roos C, Roubertie A, Barbance C, et al
    Hemiplegic Migraine Associated With PRRT2 Mutations: A Clinical and Genetic Study.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012947.
    PubMed     Abstract available


  24. GUO Y, Daghlas I, Gormley P, Giulianini F, et al
    Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subtractions.
    Neurology. 2021 Oct 11. pii: WNL.0000000000012919.
    PubMed     Abstract available


    September 2021
  25. STANYER EC, Creeney H, Nesbitt AD, Robert Holland PR, et al
    Subjective Sleep Quality and Sleep Architecture in Patients With Migraine: A Meta-analysis.
    Neurology. 2021 Sep 22. pii: WNL.0000000000012701.
    PubMed     Abstract available


  26. KAISER EA, McAdams H, Igdalova A, Haggerty EB, et al
    Reflexive Eye Closure in Response to Cone and Melanopsin Stimulation: A Study of Implicit Measures of Light Sensitivity in Migraine.
    Neurology. 2021 Sep 7. pii: WNL.0000000000012734.
    PubMed     Abstract available


  27. VAN CASTEREN DS, Verhagen IE, van der Arend BWH, van Zwet EW, et al
    Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
    Neurology. 2021 Sep 7. pii: WNL.0000000000012723.
    PubMed     Abstract available


    August 2021
  28. SCHANKIN CJ, Denier N, El-Koussy M, Wiest R, et al
    Author Response: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series.
    Neurology. 2021;97:402.
    PubMed    


  29. BUGNICOURT JM, Godefroy O
    Reader Response: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series.
    Neurology. 2021;97:401-402.
    PubMed    


    July 2021
  30. CARVALHO G, Mehnert J, Basedau H, Luedtke K, et al
    Brain Processing of a Visual Self-Motion Study in Patients With Migraine: An fMRI Study.
    Neurology. 2021 Jul 21. pii: WNL.0000000000012443.
    PubMed     Abstract available


    April 2021
  31. MACDONALD CJ, El Fatouhi D, Madika AL, Fagherazzi G, et al
    Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000011986.
    PubMed     Abstract available


  32. GHANIZADA H, Al-Mahdi Al-Karagholi M, Arngrim N, Morch-Rasmussen M, et al
    Effect of Adrenomedullin on Migraine-like Attacks in Patients With Migraine: A Randomized Crossover Study.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011930.
    PubMed     Abstract available


  33. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:686.
    PubMed    


  34. MINEN MT
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:685.
    PubMed    


  35. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684-685.
    PubMed    


  36. BLUMENFELD A
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:684.
    PubMed    


  37. LIPTON RB, Buse DC, Friedman BW
    Author Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683-684.
    PubMed    


  38. GUPTA VK
    Reader Response: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:683.
    PubMed    


  39. GANESH A, Galetta S
    Editors' Note: Characterizing Opioid Use in a US Population With Migraine: Results From the CaMEO Study.
    Neurology. 2021;96:682.
    PubMed    


  40. GUO Y, Rist PM, Sabater Lleal M, de Vries P, et al
    Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
    Neurology. 2021 Apr 1. pii: WNL.0000000000011931.
    PubMed     Abstract available


    February 2021
  41. YU AYX, Hill MD, Asdaghi N, Boulanger JM, et al
    Sex Differences in Diagnosis and Diagnostic Revision of Suspected Minor Cerebral Ischemic Events.
    Neurology. 2021;96:e732-e739.
    PubMed     Abstract available


    January 2021
  42. VAN CASTEREN DS, Kurth T, Danser AHJ, Terwindt GM, et al
    Sex Differences in Response to Triptans: A Systematic Review and Meta-analysis.
    Neurology. 2021;96:162-170.
    PubMed     Abstract available


    November 2020
  43. RIGGINS NY, Sawhney H, Ehrlich A, Parekh M, et al
    Inpatient infusion treatments of headache in patients with chronic migraine and a reported history of head trauma and endocrine co-morbidities.
    Neurology. 2020;95.
    PubMed     Abstract available


  44. ROBBINS MS, Victorio MC, Bailey M, Cook C, et al
    Quality improvement in neurology: Headache Quality Measurement Set.
    Neurology. 2020;95:866-873.
    PubMed    


    October 2020
  45. LIPTON RB, Fanning KM, Buse DC, Martin VT, et al
    Author response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707-708.
    PubMed    


  46. GUPTA VK
    Reader response: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:707.
    PubMed    


  47. SIEGLER JE 3RD, Galetta S
    Editors' note: Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
    Neurology. 2020;95:706.
    PubMed    


  48. SASIKUMAR S, Micieli JA, Oh J
    Mystery Case: Migraine, hearing loss, and blurred vision in a young woman.
    Neurology. 2020 Oct 12. pii: WNL.0000000000011034.
    PubMed    


    September 2020
  49. KORNBLUH AB, Chung MG
    Teaching NeuroImages: Transient cytotoxic edema in a child with a novel ATP1A2 mutation.
    Neurology. 2020;95:e1441-e1442.
    PubMed    


    August 2020
  50. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: